Feedback Share Discussion Threads

[someuwin] 07/10/2015 14:04

This will surely multi-bag over the next few months.

So many different medical applications for its imaging tech.

[lr2] 07/10/2015 14:04

All you need is patience.

[market master] 07/10/2015 14:00

It's unreal that the share price here is so low after that cracking rns of yesterday!

[market master] 07/10/2015 13:53

No stock available online; could move up soon!!

[blueball] 07/10/2015 10:31

This stock is best to buy and hold 5p short term.

[someuwin] 07/10/2015 08:48

Stock very tight again - this will be going up.

[blueball] 07/10/2015 08:20

Off 10% today back to square one.

[someuwin] 07/10/2015 07:56

This still looks dirt cheap to me.

Genuine multi-bagger potential from here.

[andrbea] 06/10/2015 18:36

would have expected a much bigger rise. think of how many people die globally from prostrate cancer. tomorrow maybe, early days....

[blueball] 06/10/2015 18:24

stay long.

[lr2] 06/10/2015 16:05

Price moved down but still only small amount available.

75k at 2.7375p

[lr2] 06/10/2015 15:58

Agreed - max available online 35k at 2.93p = £1,025,50.

[someuwin] 06/10/2015 15:53

Can buy £1k, but can't buy £2k worth.

[someuwin] 06/10/2015 14:31

Look how the volume has been rising recently, but has gone ballistic today.

Very significant imo...

[someuwin] 06/10/2015 14:27

Thanks LR2 - very impressive.

[lr2] 06/10/2015 14:23

SomeUWin... and melanoma.



MATERIALS AND METHODS. This retrospective study included 42 patients with metastatic melanoma who received bevacizumab therapy in the context of a randomized prospective phase II clinical trial. Target lesions on the baseline and initial posttherapy contrast-enhanced CT examinations were evaluated by CT texture analysis using TexRAD software before and after image filtering in patients with RECIST SD on initial posttherapy images. Cox proportional hazards models were used to assess the associations of CT texture analysis measurements and of other patient factors with OS. The AUC was used to evaluate predictive accuracy.

[impvesta] 06/10/2015 14:16

This looks a potentially very exciting company and I've been DMOR to assess this as a possible investment. Looks as if I am a few days late (!!) but I am trying to get my head round the company structure.

If I understand correctly the company does not have any executive directors, all three directors being NEDs. Is this correct? Who is actually running the company?

From a shareholding control point of view Trevor Brown and Tom Charlton can clearly call the shots as, according to the RNS on 3rd June, they own 51% of the company between them (Brown 27.29%, Charlton 24.53%).

Do this BB's regulars see either of these points as an issue? I'm interested in your views.

Impvesta

[someuwin] 06/10/2015 14:14

...Wow - this has amazing potential.

[someuwin] 06/10/2015 14:02

Prostate cancer

Lung cancer

Research sale to China

positive results from renal cell cancer trial

JV with Quibim.

Kidney stones / Urology product.

Research sale to Canada

University of Texas

etc etc.

[lr2] 06/10/2015 13:51

3.07p - 3.475p (max 25k available online).

Britstox, "First we take Manhattan then we take Berlin..."

[cheaky monkey] 06/10/2015 13:48

The spread is a killer though!

[britstox] 06/10/2015 13:27

Next stop global domination? ; )

[britstox] 06/10/2015 13:27

Well LR2 and Blueball...what can I say? Happy is not the word. It's finally getting the recognition it deserves. We were right!

[blueball] 06/10/2015 13:24

Surprise Mike Walters hasn't picked up on this one I used to be a subscriber in the past.